Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Czechia

Marie Skłodowska-Curie Action · Running

OSTEOCHON Development of advanced bioglass-polymer scaffolds for OSTEOCHONdral interface tissue regeneration

Coordinator
Vysoka Skola Chemicko-Technologicka V Praze, Czechia
Runs
1 September 2023 to 31 August 2025
Status
Running
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101110312

What the project is doing

In the project's own words, from its summary on CORDIS.

Damage to the osteochondral interface (OCI) is a serious health problem associated with the development of osteoarthritis affecting the lives of millions of people. However, current treatment tools have imitations leading to unsatisfactory clinical outcomes. This project aims to solve the problem by a complex approach combining and advancing recent findings in the field of tissue engineering (TE). It is accepted that patient cells can be seeded onto artificial scaffolds containing biologically active substances (BASs) to stimulate these cells to new tissue formation.

We take the view that the scaffold should consist of a soft part and a sufficiently stiff part to avoid the formation of unwanted fibrocartilage. We will use cryogelation and 3D-printed bioactive glass to prepare multiphasic scaffolds that can carry regulatory signals for adipose-derived stem cells (ADSCs). Our research objectives are to develop 1) a stiff scaffold with a graded structure matching the morphology of the subchondral bone and able to be loaded by BASs to facilitate osteogenesis, 2) a soft scaffold based on a cryogel enriched by BASs to facilitate chondrogenesis, and 3) a combined scaffold matching the zonal structure of OCI to enhance its regeneration. 4) We will use ADSCs and modern ex vivo testing protocols to evaluate the potential of the scaffold to meet the needs of OCI TE, and to direct future research to in vivo testing and commercialization.

The research will be conducted within the academic structures of the University of Chemistry and Technology (UCT) in Prague, Czech Republic, in collaboration with the Biotechnology and Biomedicine Center in Vestec (BIOCEV) near Prague, under the supervision of Prof. Jan Merna and Prof. Bacakova.

Topics

Who is involved

OrganisationCityCountryRole
Vysoka Skola Chemicko-Technologicka V PrazePrahaCzechiaCoordinator
Fyziologicky Ustav Akademie Ved Ceske Republiky Verejna Vyzkumna Instituce (vvi)Praha 4CzechiaAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI